Small biotech trials face hidden supply risks that waste up to 75% of materials, delay timelines, and drain funding faster. Learn what causes them and how to prevent them.
- The RTSM–EDC Integration Trap: Why Broken Workflows Still Undermine Trial Execution
- Building Win-Win Partnerships In Clinical Trial Supply
- The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early
- Bridging Preclinical Science And Trial Supply Success
- The New Reality Of Clinical Trial Logistics
- Drug Shortages In Clinical Trials: A Policy Blueprint
- Leading Clinical Trial Supply Teams: Insights And Best Practices
- Designing Clinical Trials For Hard-To-Access Patients
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
RTSM: Randomization And Cohort Management, IP Inventory Management
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Consolidating Clinical Supply Chain Operations With GxP Inventory
A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
How To Build Effective Clinical Trial Oversight And Leadership
In a collaborative outsourcing model, the sponsor maintains direct contact with functional leads, eliminating communication gaps and enabling faster, better-informed decision-making.
-
GxP Inventory Enhances Supply Chain For Global Specialty Biotech Firm
Discover how the simplification and digitization of clinical supply chain operations enhanced transparency, lowered risks and expenses, and optimized efficiency.
-
Key Considerations For Labeling Your Cell Or Gene Therapy
As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.
-
Planning Your Packaging For A Seamless Transition From Clinic To Launch
Explore how clinical and commercial teams should work together for clinical supply packaging, how the COVID-19 pandemic has changed things, and what to consider when looking for a packaging partner.
-
Overcoming Challenges In Cell And Gene Therapy Containment
Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
Enhancing Quality And Efficiency Through Digitized Clinical Secondary Packaging Processes
Explore how an innovative software platform can be used to create customized, user-friendly applications to digitize clinical secondary packaging processes.
-
Logistics, Transport Challenges Require Complex Solutions
The pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.